Clinically Employed Opioid Analgesics Produce Antinociception via μ-δ Opioid Receptor Heteromers in Rhesus Monkeys

Citations Over TimeTop 12% of 2012 papers

Abstract

Morphine and related drugs are widely employed as analgesics despite the side effects associated with their use. Although morphine is thought to mediate analgesia through mu opioid receptors, delta opioid receptors have been implicated in mediating some side effects such as tolerance and dependence. Here we present evidence in rhesus monkeys that morphine, fentanyl, and possibly methadone selectively activate mu-delta heteromers to produce antinociception that is potently antagonized by the delta opioid receptor antagonist, naltrindole (NTI). Studies with HEK293 cells expressing mu-delta heteromeric opioid receptors exhibit a similar antagonism profile of receptor activation in the presence of NTI. In mice, morphine was potently inhibited by naltrindole when administered intrathecally, but not intracerebroventricularly, suggesting the possible involvement of mu-delta heteromers in the spinal cord of rodents. Taken together, these results strongly suggest that, in primates, mu-delta heteromers are allosterically coupled and mediate the antinociceptive effects of three clinically employed opioid analgesics that have been traditionally viewed as mu-selective. Given the known involvement of delta receptors in morphine tolerance and dependence, our results implicate mu-delta heteromers in mediating both antinociception and these side effects in primates. These results open the door for further investigation in humans.

Related Papers

• → The role of δ-opioid receptor subtypes in neuropathic pain(2001)88 cited
• → Several δ-opioid receptor ligands display no subtype selectivity to the human δ-opioid receptor(2002)35 cited
• → δ-Opioid receptor: the third extracellular loop determines naltrindole selectivity(1996)21 cited
• → G-protein coupling of δ-opioid receptors in brains of μ-opioid receptor knockout mice(2003)4 cited
• [Dual regulation by delta opioid receptor agonists on the delayed rectified potassium channels in NG108-15 cells].(2003)